Home › Funds › Carmignac Gestion › COR
Carmignac Gestion position in COR
CENCORA INC · Health Care
Carmignac Gestion reported holding 1,344,823 shares of COR (CENCORA INC) in its Q3 2026 13F filing — a position valued at US$403.8M, representing 6.42% of its reported portfolio and ranking #2 among its reported holdings. Carmignac Gestion has disclosed COR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Carmignac Gestion's COR position evolved
Carmignac Gestion first disclosed a stake in COR in Q2 2024 at 963,873 shares (US$217.2M). The position peaked in Q2 2026 at 1,747,363 shares, worth US$494.5M. Across 10 filings, Carmignac Gestion increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,344,823 shares valued at US$403.8M — a reduction of -402,540 shares quarter over quarter.. Notable position changes include a 26% increase in Q1 2026 (shares fell 10% over the following quarter), a 59% increase in Q2 2026 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 963.87K | $217.16M | New |
| Q3 2024 | 1.02M | $229.58M | Add |
| Q4 2024 | 1.00M | $225.02M | Reduce |
| Q1 2025 | 1.10M | $306.86M | Add |
| Q2 2025 | 922.49K | $276.61M | Reduce |
| Q3 2025 | 875.85K | $273.71M | Reduce |
| Q4 2025 | 875.10K | $295.57M | Hold |
| Q1 2026 | 1.10M | $345.93M | Add |
| Q2 2026 | 1.75M | $494.46M | Add |
| Q3 2026 | 1.34M | $403.82M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COR and 13F data
COR (CENCORA INC) is a Health Care company. 32 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.58B), Mawer Investment Management Ltd. (US$413.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COR
- T. Rowe Price Investment Management, Inc. 7.41M sh · $2.10B · Q2 2026
- Boston Partners 5.25M sh · $1.58B · Q3 2026
- Mawer Investment Management Ltd. 1.38M sh · $413.03M · Q3 2026
- BESSEMER GROUP INC 1.26M sh · $376.94M · Q3 2026
More on Carmignac Gestion
FAQ
How long has Carmignac Gestion held COR?
Carmignac Gestion has disclosed COR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Carmignac Gestion's current position in COR?
As of Q3 2026, Carmignac Gestion holds 1.34M shares of COR (CENCORA INC), valued at $403.82M, representing 6.42% of its reported portfolio and ranking #2.
Has Carmignac Gestion been buying or selling COR?
In the latest 13F filing (Q3 2026), Carmignac Gestion reduced its position in COR. The position peaked in Q2 2026 at 1.75M shares.
Which other funds hold COR?
Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Mawer Investment Management Ltd., among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.